We actively seek collaborations with global pharmaceutical companies and leading enterprises in specialized fields, focusing on:
Pipeline Product Rights: Engaging in global or regional rights collaborations to maximize clinical and commercial value for patients worldwide.
Production Technology Platform: Leveraging our Sf9 production technology to provide one-stop process development and manufacturing solutions for AAV gene therapy companies.

We partner with leading venture capital, private equity, and industry funds to meet our equity financing needs. This funding fuels the clinical progress of our pipeline, allowing all stakeholders to share in the company's growth.